• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
History-adjusted marginal structural models for estimating time-varying effect modification.用于估计时变效应修正的历史调整边际结构模型。
Am J Epidemiol. 2007 Nov 1;166(9):985-93. doi: 10.1093/aje/kwm232. Epub 2007 Sep 17.
2
Effect modification by time-varying covariates.随时间变化的协变量对效应的修正
Am J Epidemiol. 2007 Nov 1;166(9):994-1002; discussion 1003-4. doi: 10.1093/aje/kwm231. Epub 2007 Sep 17.
3
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures.使用重复测量的边际结构模型估计齐多夫定对CD4细胞计数的因果效应。
Stat Med. 2002 Jun 30;21(12):1689-709. doi: 10.1002/sim.1144.
4
Estimating causal treatment effects from longitudinal HIV natural history studies using marginal structural models.使用边际结构模型从纵向HIV自然史研究中估计因果治疗效果。
Biometrics. 2003 Mar;59(1):152-62. doi: 10.1111/1541-0420.00018.
5
A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV.一种边际结构模型,用于估计抗抑郁药物治疗对无家可归和居住条件差的艾滋病毒感染者病毒抑制的因果效应。
Arch Gen Psychiatry. 2010 Dec;67(12):1282-90. doi: 10.1001/archgenpsychiatry.2010.160.
6
Marginal Structural Models: unbiased estimation for longitudinal studies.边缘结构模型:纵向研究的无偏估计。
Int J Public Health. 2011 Feb;56(1):117-9. doi: 10.1007/s00038-010-0198-4. Epub 2010 Oct 8.
7
Marginal Structural Models with Counterfactual Effect Modifiers.具有反事实效应修饰因子的边际结构模型。
Int J Biostat. 2018 Jun 8;14(1):/j/ijb.2018.14.issue-1/ijb-2018-0039/ijb-2018-0039.xml. doi: 10.1515/ijb-2018-0039.
8
Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.在埃塞俄比亚长期抗逆转录病毒治疗下病毒持续抑制的 HIV-1 感染患者中的免疫恢复。
PLoS One. 2020 Oct 22;15(10):e0240880. doi: 10.1371/journal.pone.0240880. eCollection 2020.
9
Instrumental variables and inverse probability weighting for causal inference from longitudinal observational studies.纵向观察性研究因果推断的工具变量与逆概率加权法
Stat Methods Med Res. 2004 Feb;13(1):17-48. doi: 10.1191/0962280204sm351ra.
10
Statistical learning of origin-specific statically optimal individualized treatment rules.特定起源的静态最优个体化治疗规则的统计学习
Int J Biostat. 2007;3(1):Article 6. doi: 10.2202/1557-4679.1040.

引用本文的文献

1
A Review of Causal Inference Methods for Estimating the Effects of Exposure Change When Incident Exposure Is Unobservable.当无法观察到事件暴露时用于估计暴露变化影响的因果推断方法综述
Curr Epidemiol Rep. 2024 Dec;11(4):185-198. doi: 10.1007/s40471-024-00343-5. Epub 2024 Feb 19.
2
History-restricted marginal structural model and latent class growth analysis of treatment trajectories for a time-dependent outcome.针对时间依赖性结局的治疗轨迹的历史受限边际结构模型和潜在类别增长分析。
Int J Biostat. 2024 Aug 12;20(2):467-490. doi: 10.1515/ijb-2023-0116. eCollection 2024 Nov 1.
3
Air pollution and serious bleeding events in high-risk older adults.空气污染与高危老年人严重出血事件。
Environ Res. 2024 Jun 15;251(Pt 1):118628. doi: 10.1016/j.envres.2024.118628. Epub 2024 Mar 7.
4
Retrospective cohort study investigating synergism of air pollution and corticosteroid exposure in promoting cardiovascular and thromboembolic events in older adults.回顾性队列研究调查空气污染和皮质类固醇暴露在促进老年人心血管和血栓栓塞事件中的协同作用。
BMJ Open. 2023 Sep 13;13(9):e072810. doi: 10.1136/bmjopen-2023-072810.
5
Causal inference in survival analysis using longitudinal observational data: Sequential trials and marginal structural models.使用纵向观察数据进行生存分析中的因果推断:序贯试验和边际结构模型。
Stat Med. 2023 Jun 15;42(13):2191-2225. doi: 10.1002/sim.9718. Epub 2023 Apr 22.
6
Assessing Heterogeneity of Treatment Effect in Real-World Data.评估真实世界数据中治疗效果的异质性。
Ann Intern Med. 2023 Apr;176(4):536-544. doi: 10.7326/M22-1510. Epub 2023 Mar 21.
7
Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysis.在个体患者数据分析荟萃分析中建立耐多药结核病治疗效果的修饰模型。
Stat Methods Med Res. 2022 Apr;31(4):689-705. doi: 10.1177/09622802211046383. Epub 2021 Dec 13.
8
Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry.CARTITUDE-1研究患者与德国登记处中先前接受过蛋白酶体抑制剂(PI)、免疫调节剂(Imid)和抗CD-38治疗的多发性骨髓瘤患者之间结局的校正比较。
Cancers (Basel). 2021 Nov 29;13(23):5996. doi: 10.3390/cancers13235996.
9
Double robust estimation for multiple unordered treatments and clustered observations: Evaluating drug-eluting coronary artery stents.针对多种无序治疗和聚类观察的双重稳健估计:评估药物洗脱冠状动脉支架。
Biometrics. 2019 Mar;75(1):289-296. doi: 10.1111/biom.12927. Epub 2018 Jul 13.
10
Estimating long-term treatment effects in observational data: A comparison of the performance of different methods under real-world uncertainty.在观察性数据中估计长期治疗效果:在现实世界不确定性下不同方法性能的比较。
Stat Med. 2018 Jul 10;37(15):2367-2390. doi: 10.1002/sim.7664. Epub 2018 Apr 19.

本文引用的文献

1
Deletion/substitution/addition algorithm in learning with applications in genomics.学习中的删除/替换/添加算法及其在基因组学中的应用
Stat Appl Genet Mol Biol. 2004;3:Article18. doi: 10.2202/1544-6115.1069. Epub 2004 Aug 12.
2
Administration of parenteral iron and mortality among hemodialysis patients.胃肠外铁剂给药与血液透析患者的死亡率
J Am Soc Nephrol. 2004 Jun;15(6):1623-32. doi: 10.1097/01.asn.0000128009.69594.be.
3
Treatment of antiretroviral-drug-resistant HIV-1 infection.抗逆转录病毒药物耐药性HIV-1感染的治疗。
Lancet. 2003 Dec 13;362(9400):2002-11. doi: 10.1016/S0140-6736(03)15022-2.
4
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.尽管血浆病毒血症可检测到,但仍继续接受联合治疗的患者中CD4 T细胞增加的持续时间和预测因素。
AIDS. 2002 Jan 25;16(2):201-7. doi: 10.1097/00002030-200201250-00009.
5
Long-term clinical outcome of human immunodeficiency virus-infected patients with discordant immunologic and virologic responses to a protease inhibitor-containing regimen.对含蛋白酶抑制剂方案呈现免疫和病毒学反应不一致的人类免疫缺陷病毒感染患者的长期临床结局
J Infect Dis. 2001 May 1;183(9):1328-35. doi: 10.1086/319861. Epub 2001 Mar 29.
6
Marginal structural models and causal inference in epidemiology.边缘结构模型与流行病学中的因果推断
Epidemiology. 2000 Sep;11(5):550-60. doi: 10.1097/00001648-200009000-00011.
7
Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection.人类免疫缺陷病毒感染患者中基于蛋白酶抑制剂的治疗方案病毒学失败后的持续性CD4 + T细胞应答。
J Infect Dis. 2000 Mar;181(3):946-53. doi: 10.1086/315334.

用于估计时变效应修正的历史调整边际结构模型。

History-adjusted marginal structural models for estimating time-varying effect modification.

作者信息

Petersen Maya L, Deeks Steven G, Martin Jeffrey N, van der Laan Mark J

机构信息

Division of Biostatistics, School of Public Health, University of California, Berkeley, Berkeley, CA 94720, USA.

出版信息

Am J Epidemiol. 2007 Nov 1;166(9):985-93. doi: 10.1093/aje/kwm232. Epub 2007 Sep 17.

DOI:10.1093/aje/kwm232
PMID:17875580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2561999/
Abstract

Much of epidemiology and clinical medicine is focused on estimating the effects of treatments or interventions administered over time. In such settings of longitudinal treatment, time-dependent confounding is often an important source of bias. Marginal structural models (MSMs) are a powerful tool for estimating the causal effect of a treatment using observational data, particularly when time-dependent confounding is present. In recent statistical work, van der Laan et al. presented a generalized form of MSMs called "history-adjusted" MSMs (Int J Biostat 2005;1:article 4). Unlike standard MSMs, history-adjusted MSMs can be used to estimate modification of treatment effects by time-varying covariates. Estimation of time-dependent causal effect modification is frequently of great practical relevance. For example, clinical researchers are often interested in how the prognostic significance of a biomarker for treatment response can change over time. This article provides a practical introduction to the implementation and interpretation of history-adjusted MSMs. The method is illustrated using a clinical question drawn from the treatment of human immunodeficiency virus infection. Observational cohort data from San Francisco, California, collected between 2000 and 2004, are used to estimate the effect of time until switching antiretroviral therapy regimens among patients receiving a non suppressive regimen and how this effect differs depending on CD4-positive T-lymphocyte count.

摘要

流行病学和临床医学的很多内容都聚焦于评估随时间推移给予的治疗或干预措施的效果。在这种纵向治疗的情况下,时间依存性混杂因素常常是偏差的一个重要来源。边际结构模型(MSMs)是利用观察性数据估计治疗因果效应的有力工具,尤其是在存在时间依存性混杂因素时。在最近的统计学研究中,范德·拉恩等人提出了一种广义形式的MSMs,称为“历史调整”MSMs(《国际生物统计学杂志》2005年;1:第4篇文章)。与标准MSMs不同,历史调整MSMs可用于估计随时间变化的协变量对治疗效果的修正。估计时间依存性因果效应修正常常具有重大的实际意义。例如,临床研究人员常常对生物标志物对治疗反应的预后意义如何随时间变化感兴趣。本文对历史调整MSMs的实施和解释进行了实际介绍。该方法通过一个来自人类免疫缺陷病毒感染治疗的临床问题进行说明。使用加利福尼亚州旧金山在2000年至2004年期间收集的观察性队列数据,来估计接受非抑制性治疗方案的患者在转换抗逆转录病毒治疗方案之前的时间效应,以及这种效应如何因CD4阳性T淋巴细胞计数而异。